|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0042523,
umls-concept:C0087111,
umls-concept:C0332152,
umls-concept:C0392756,
umls-concept:C0439185,
umls-concept:C0441471,
umls-concept:C0679199,
umls-concept:C1512888
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-7-28
|
|
pubmed:abstractText |
In patients with prior myocardial infarction (MI), beta-blockers reduce mortality by 23% to 40%. However, despite this favorable effect, adverse effects limit compliance to this medication. The purpose of the study was to compare a beta-blocker-based strategy with a heart rate-lowering calcium antagonists-based strategy in patients with prior MI.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
pubmed-author:BacherPeter HPH,
pubmed-author:BangaloreSripalS,
pubmed-author:ChampionAnnetteA,
pubmed-author:CohenJerome DJD,
pubmed-author:INVEST Investigators,
pubmed-author:KoweyPeterP,
pubmed-author:ManciaGiuseppeG,
pubmed-author:MesserliFranz HFH,
pubmed-author:PepineCarl JCJ,
pubmed-author:SleightPeterP,
pubmed-author:ZhouQianQ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
156
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
241-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18657652-Adrenergic beta-Antagonists,
pubmed-meshheading:18657652-Aged,
pubmed-meshheading:18657652-Angina Pectoris,
pubmed-meshheading:18657652-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:18657652-Atenolol,
pubmed-meshheading:18657652-Calcium Channel Blockers,
pubmed-meshheading:18657652-Delayed-Action Preparations,
pubmed-meshheading:18657652-Drug Therapy, Combination,
pubmed-meshheading:18657652-Female,
pubmed-meshheading:18657652-Follow-Up Studies,
pubmed-meshheading:18657652-Humans,
pubmed-meshheading:18657652-Hypertension,
pubmed-meshheading:18657652-Indoles,
pubmed-meshheading:18657652-Male,
pubmed-meshheading:18657652-Middle Aged,
pubmed-meshheading:18657652-Myocardial Infarction,
pubmed-meshheading:18657652-Proportional Hazards Models,
pubmed-meshheading:18657652-Risk,
pubmed-meshheading:18657652-Single-Blind Method,
pubmed-meshheading:18657652-Stroke,
pubmed-meshheading:18657652-Verapamil
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
|
|
pubmed:affiliation |
Division of Cardiovascular Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
